C2C Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$332K Hold
1,254
– – 0.26% 67
2026
Q2
$318K Hold
1,254
– – 0.25% 70
2026
Q1
$306K Hold
1,254
– – 0.26% 70
2025
Q4
$259K Hold
1,254
– – 0.22% 73
2025
Q3
$232K Buy
+1,254
New +$215K 0.2% 79
2025
Q2
– Sell
-1,254
Closed -$208K – 85
2025
Q1
$208K Buy
+1,254
New +$196K 0.2% 81
2024
Q4
– Sell
-1,254
Closed -$200K – 90
2024
Q3
$200K Buy
+1,254
New +$200K 0.19% 84
2024
Q1
– Sell
-2,161
Closed -$338K – 99
2023
Q4
$338K Sell
2,161
-10,392
-83% -$1.59M 0.29% 72
2023
Q3
$1.94M Buy
12,553
+300
+2% +$49.5K 0.28% 39
2023
Q2
$1.95M Sell
12,253
-301
-2% -$48.6K 0.26% 40
2023
Q1
$2.06M Buy
12,554
+402
+3% +$64.9K 0.33% 36
2022
Q4
$2.07M Sell
12,152
-3,017
-20% -$521K 0.36% 30
2022
Q3
$2.51M Sell
15,169
-116
-0.8% -$19.6K 0.49% 19
2022
Q2
$2.62M Buy
15,285
+2
+0% +$356 0.48% 23
2022
Q1
$2.81M Sell
15,283
-98
-0.6% -$16.7K 0.48% 27
2021
Q4
$2.63M Buy
+15,381
New +$2.52M 0.38% 31

Other funds holding JNJ

C2C Wealth Management's JNJ Position: Q3 2026 in Review

C2C Wealth Management held its Johnson & Johnson (JNJ) position steady in Q3 2026 at 1,254 shares worth $332K. The position accounts for 0.26% of the portfolio, ranked #67.

C2C Wealth Management first reported a position in JNJ in Q4 2021 and has held it in 16 quarters since. The position peaked at $2.81M in Q1 2022. 4,243 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • C2C Wealth Management held 1,254 shares of Johnson & Johnson worth $332K as of Q3 2026.
  • C2C Wealth Management left its Johnson & Johnson share count unchanged in Q3 2026.
  • Johnson & Johnson made up 0.26% of C2C Wealth Management's portfolio in Q3 2026, its #67 holding.
  • C2C Wealth Management first reported a position in Johnson & Johnson in Q4 2021 and has held it in 16 quarters since.
  • C2C Wealth Management's Johnson & Johnson position peaked at $2.81M in Q1 2022.
  • 4,243 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on C2C Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.